Morgan Stanley on Brexit - do not see more clarity until early February at earliest

16/01/2019 | 23:11 GMT

From an MS note in the wake of PM may's deal vote defeat (seems like years ago doesn't it?)

MS outline what's next (on a timeline) and alternatives, quite a useful summary though with the situation so fluid who know what else could pop up.

ADVERTISEMENT - CONTINUE READING BELOW

Best in 2026

Sponsored

General Risk Warning

Best Prop Firm in 2026: Detailed Comparison

Best Futures Brokers in USA for 2026: Detailed Comparison

Best Prediction Market Platforms in 2026: Detailed Comparison

Best Forex Brokers in 2026: Detailed Comparison

Best Online Brokers in 2026: Detailed Comparison

ADVERTISEMENT - CONTINUE READING BELOW

Telegram Community

Gain Access

AXSM jumps 22.9% on Alzheimer's drug approval; analysts raise price targets to $255.

Motley Fool

34s ago

PWR beats revenue/EPS estimates, lifts guidance. Strong backlog growth signals robust demand.

StockStory

7m ago

Heathrow's £49B runway faces airline pushback over costs; China fund eyes exit amid risk.

Telegraph

14m ago

ZTS's 9.1% revenue growth & 16.2x P/E show promise; IBM & CSGP face headwinds with soft growth & high P/E.

StockStory

18m ago

Amtrak secures $33B infrastructure funds, cutting costs on Baltimore tunnel project to $5B.

Bloomberg

21m ago

Micron's revenue booms on AI demand, but cyclical risks loom. Priced low at 8.6x earnings, will it soar or crash?

Motley Fool

25m ago

WDAY's 3x P/S valuation & slow ARR growth raise flags. ALIT's sales drop & EPS decline make it risky.

StockStory

29m ago

Telegram Community

Gain Access

Must Read

!"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}